Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding

References

• Nakajima T, Harashima S, Hirata M, Kajitani T. Prognostic therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 1978; 22: 225–229
   PubMedGoogle Scholar
• Kiyasu Y, Kaneshima S, Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 1981; 41: 1236–1239
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, Katayama K, Tanaka S, Hirono Y, Miwa K, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995; 19: 450–455
   PubMed Web of Science ®Google Scholar
• Levi JA, Fox RM, Tattersall MH, Woods RL, Thompson D, Gill G. Analysis of a prospectively randomized comparison doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: Implication for future studies. J Clin Oncol 1986; 4: 1348–1355
   PubMed Web of Science ®Google Scholar
• Overgaard J. Effect of hyperthermia on malignant cells in vivo. Cancer 1977; 39: 2637–2646
   PubMed Web of Science ®Google Scholar
• Hettinga JVE, Konings AWT, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia–A review. Int J Hyperthermia 1997; 13: 439–457
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Y, Mizutani M, Chikenji T, Okui K. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990; 212: 592–596
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Isawa E, Sumida M, Ohkubo H. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined surgery. Cancer 1997; 79: 884–891
   PubMed Web of Science ®Google Scholar
• ujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999; 85: 529–534
   PubMedGoogle Scholar
• Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004; 18: 2727–2730
   Google Scholar
• Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005; 92: 370–375
   PubMed Web of Science ®Google Scholar
• Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6: 790–796
   PubMed Web of Science ®Google Scholar
• Abe M, Hiraoka M, Takahashi M, Ono K, Nohara H. Clinical experience with microwave and radiofrequency thermotherapy in the treatment of advanced cancer. Natl Cancer Inst Monogr 1982; 61: 411–414
   Google Scholar
• Abe M, Hiraoka M, Takahashi M, Egawa S, Matsuda C, Onoyama Y, Morita K, Kakehi M, Sugahara T. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 1986; 58: 1589–1595
   PubMed Web of Science ®Google Scholar
• Gilly FN, Cotte E, Brigand C, Monneuse O, Beaujard AC, Freyer G, Glehen O. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol. 2006; 32: 597–601
   PubMedGoogle Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221: 29–42
   PubMed Web of Science ®Google Scholar
• Abe M, Hiraoka M. Localized hyperthermia and radiation in cancer therapy; Review. Int J Radiat Biol 1985; 47: 347–359
   Web of Science ®Google Scholar
• Tahara M, Ohtsu A, Narikazu B, et al. Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study. Gastric cancer 2001; 3: 212–218
   Google Scholar
• Hall JJ, Loggie BW, Shen P, Beamer S, Case LD, MaQuellon R, Geisinger KR, Levine EA. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointestinal Surg 2004; 8: 454–463
   PubMed Web of Science ®Google Scholar
• Son CW, Shakil A, Osborn JL, Iwata K. Tumor oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1999; 15: 79–107
   PubMedGoogle Scholar
• Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin N America 1989; 27: 621–627
   PubMed Web of Science ®Google Scholar
• Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). 2001, 4: 27–33
   Google Scholar
• Jones RB, Myers CE, Guarino AM, et al. High volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer. Pharmacologic basis and early results. Cancer Chemother Pharmacol 1978; 5: 1607–1612
   Google Scholar
• Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemotherapy. Lancet Oncol 2004; 5: 219–228
   PubMed Web of Science ®Google Scholar
• Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y, Sugimachi K. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery 2002; 131: S78–S84
   PubMed Web of Science ®Google Scholar
• Hettinga JVE, Konings AWT, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia–A review. Int J Hyperthermia 1997; 13: 439–457
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial. Int J Hyperthermia 1994; 10: 485–493
   PubMed Web of Science ®Google Scholar
• Wallner KE, Li GC. Effect of drug exposure duration and sequencing on hyperthermia potentiation of mitomycin C and cisplatin. Cancer Res 1987; 47: 493–496
   PubMed Web of Science ®Google Scholar
• Wallner KE, Degregorio MW, Li GC. Hyperthermia potentiation of cis-diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar
• Ohno S, Siddik ZH, Kido Y, Zwelling LA, Bull JMC. Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol 1994; 34: 343–350
   Google Scholar
• Hettinge JV, Lemstra W, Meijer C, Dam WA, Uges DRA, Konings AWK. Mechanism of hyperthermia potentiation of cisplatin action in cisplatin-sensitive and–resistant tumor cells. Br J Cancer 1997; 75: 1735–1743
   PubMedGoogle Scholar
• Diaz JF, Andreu JM. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry. 1993; 32: 2747–2755
   PubMed Web of Science ®Google Scholar
• Marchettini P, Stuart A, Mohamed F, Yoo D, Sugarbaker PH. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemother. Parmacol 2002; 49: 499–503
   PubMed Web of Science ®Google Scholar
• Morgan RJ, Jr, Doroshow JH, Synold T, Lim D, Shibata S, Margolin K, Schwarz R, Leong L, Somlo G, Twardowski P, et al. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: Dose-limiting toxicity and pharmacokinetics. Clin Cancer Res 2003; 9: 5896–5901
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Endou Y, Bando E, Kuno K, Kawamura T, Kimura M, Shimada T, Miyamoto K, Sasaki T, Sugarbaker PH. Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett 2004; 210: 189–196
   PubMedGoogle Scholar
• Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, Sugarbaker PH. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 2006; 32: 661–665
   PubMed Web of Science ®Google Scholar
• Shido A, Ohmura S, Yamamoto K, Kobayashi T, Fujimura T, Yonemura Y. Dose hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion?. World J Surg 2000; 24: 507–511
   PubMedGoogle Scholar